INS and Hyperglycemia: Therefore, if insulin resistance is not treated adequately, that is, with the introduction of agents with antioxidant and anti-inflammatory properties, performing a combination therapy with insulin and/or oral antidiabetics, it may maintain the vicious cycle of insulin resistance, which is followed by maternal hyperglycemia and failure to attenuate adverse maternal and perinatal outcomes [6,8].